相关实验视频
Updated: Sep 19, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.3K
临床表型和病原性特征在晚发性单一性炎症性肠病的综合评估:与婴儿发病病例进行比较研究
Haoying Liu1, Yinxian Shen1, Jiaxin Xu1
1Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
BMC gastroenterology
|June 5, 2025
概括
晚期发病的单一性炎症性肠病 (LO-mIBD) 呈现出类似克罗恩病的症状,并涉及表皮和细胞基因缺陷. 了解这些遗传和临床特征对于患者管理至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 16岁后发病的单一性炎症性肠病 (mIBD) (LO-mIBD) 越来越多地被认可,但了解得很少.
- 缺乏对LO-mIBD临床和遗传特征的系统性表征.
- 本研究将LO-mIBD与婴儿发作的mIBD (IO-mIBD) 进行比较,以阐明差异.
研究的目的:
- 描述晚发性单一性炎症性肠病 (LO-mIBD) 的临床和遗传特征.
- 为了将LO-mIBD与婴儿发作的mIBD (IO-mIBD) 进行比较.
- 确定参与LO-mIBD的关键基因和途径.
主要方法:
- 对病例报告,病例系列和队列 (1990-2023) 的系统文献综述.
- 在PubMed和Web of Science搜索中遵循PRISMA指南.
- 在LO-mIBD和IO-mIBD之间对人口,遗传,表型和基因型数据进行比较分析.
主要成果:
- 分析了110个LO-mIBD和436个IO-mIBD病例.
- LO-mIBD患者表现出较低的血缘关系,更多的异合主导突变和类似克罗恩病的表型.
- 关键的LO-mIBD基因包括SLCO2A1,GUCY2C,CTLA4,CYBB,SLC26A3,具有突出的上皮和细胞缺陷.
结论:
- LO-mIBD呈现出多种,主要是类似克罗恩病的肠道表型.
- 在LO-mIBD中的遗传缺陷主要影响肠道上皮质和细胞功能.
- 遗传咨询,基因型-表型相关性和途径验证对于LO-mIBD管理至关重要.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
402
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
402
Inflammatory Bowel Disease I: Ulcerative Colitis
348
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
348
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
432
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432
Chronic Bowel Disorders: Introduction
544
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
544
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
257
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
257
Inflammatory Bowel Disease IV: Pharmacological Management
205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
205

